Technion Israel Institute Technology, Haifa
ESC-derived cardiomyocytes restore myocardial electromechanical properties
Published in Law and Health Weekly, January 1st, 2005
According to recent research from Israel, "Cell therapy is emerging as a promising strategy for myocardial repair. This approach is hampered, however, by the lack of sources for human cardiac tissue and by the absence of direct evidence for functional integration of donor cells into host tissues.
"Here we investigate whether cells derived from human embryonic stem (hES) cells can restore myocardial electromechanical properties."
"Cardiomyocyte cell grafts were generated from hES cells in vitro using the embryoid body differentiating system....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biotechnology Industry Organization
Biotech group urges Congress to keep patent fees at PTO - Institute of Immunology, Zagreb
Assay to measure Fc function of immunoglobulin preparations developed - Intarcia Therapeutics Inc.
Pharmaceutical company announces new appointments to board of directors - Legal Issues
Merck appoints committee to review company actions on Vioxx - Medical Ethics
New center to study medical ethics in the care of children - Medicare
Drug card enrollment falls short - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
